Kathryn Jones

Kathryn Jones is an experienced legal professional specializing in intellectual property, with a robust background in various leadership roles. Currently serving as Vice President and Chief Counsel of IP at Novo Nordisk since January 2022, Kathryn previously held the position of General Counsel for Intellectual Property, Litigation, and Corporate at Indivior from March 2018 to December 2021. Additional roles include Senior Director of IP at Lupin Pharmaceuticals, Director of Intellectual Property at Ranbaxy, and IP Counsel at Ranbaxy Inc. Prior to these positions, Kathryn worked as an Associate at Kenyon & Kenyon and Dimock Stratton LLP. Educational qualifications include an LLB from Osgoode Hall Law School, an M.Sc. in Chemistry from Queen's University, and a background from the University of Toronto - University College.